Study harnesses a cell-type-specific, multi-target drug discovery strategy grounded in human data and real-world evidence.

Study finds two cancer drugs could slow Alzheimer's disease in mice, offering promise for reversing symptoms in humans.

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the ...

Amy and Kameel each bring an extraordinary combination of strategic vision, operational excellence, and hands-on experience developing and commercializing therapies in complex neurological and chronic ...

The Polaris International Equity Composite gained 12.40% (net of fees), outperforming the MSCI EAFE Index that returned 12.07 ...

Only e-cigarettes regulated by the FDA can be sold in Wisconsin in Wisconsin, and the FDA has consistently only regulated ...

Microbot Medical® Expands Commercial Leadership with Appointment of Christina Bailey as VP of Sales ...

PRNewswire/ - Medunik USA, a specialty pharmaceutical company dedicated to providing rare disease patients with access to orphan drugs and part of Duchesnay Pharmaceutical Group ...

More people are starting to use AI chatbots for therapy, but experts are warning users to still keep human therapists in the ...